share_log

復星醫藥：海外監管公告 - 關於職工監事變更的公告

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement on Change of Employee Supervisor

HKEX ·  Jun 19 20:07
Summary by Futu AI
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年6月19日宣布，因到齡退休，原職工監事及監事會主席任倩女士已提交書面辭職。復星醫藥表示對任倩女士在任期間的貢獻表示感謝。同日，公司召開職工代表大會，選舉王麗娜女士為新任職工監事，任期自當日起至第九屆監事會任期結束。王麗娜女士擁有豐富的人力資源管理經驗，現任復星醫藥人力資源部執行總經理及控股子公司復星健康科技（集團）有限公司副總裁等職。她自2007年加入復星醫藥集團，並於2013年獲得中國人民大學管理學碩士學位。截至2024年6月19日，王麗娜持有復星醫藥1,900股A股股份。
上海復星醫藥（集團）股份有限公司（簡稱「復星醫藥」）於2024年6月19日宣布，因到齡退休，原職工監事及監事會主席任倩女士已提交書面辭職。復星醫藥表示對任倩女士在任期間的貢獻表示感謝。同日，公司召開職工代表大會，選舉王麗娜女士為新任職工監事，任期自當日起至第九屆監事會任期結束。王麗娜女士擁有豐富的人力資源管理經驗，現任復星醫藥人力資源部執行總經理及控股子公司復星健康科技（集團）有限公司副總裁等職。她自2007年加入復星醫藥集團，並於2013年獲得中國人民大學管理學碩士學位。截至2024年6月19日，王麗娜持有復星醫藥1,900股A股股份。
On June 19, 2024, Fosun Pharma (Group) Co., Ltd. (referred to as "Fosun Pharma") announced that Ms. Ren Qian, former employee supervisor and chairman of the board of supervisors, had resigned in writing due to retirement. Fosun Pharma expressed its thanks to Ms. Ren Qian for her contributions during her term of office. On the same day, the company held a meeting of employee representatives and elected Ms. Wang Lina as the new employee supervisor, with a term of office from the date of election until the end of the ninth session of the board of supervisors. Ms. Wang Lina has rich experience in human resources management, and currently serves as the executive general manager of human resources department of Fosun Pharma and the vice president of Fosun Health Technology (Group) Co., Ltd., a subsidiary of Fosun Pharma. She joined the Fosun Pharma Group in 2007 and received a master's degree in management from Renmin University of China in 2013. As of June 19, 2024, Ms. Wang Lina holds 1,900 shares of A shares in Fosun Pharma.
On June 19, 2024, Fosun Pharma (Group) Co., Ltd. (referred to as "Fosun Pharma") announced that Ms. Ren Qian, former employee supervisor and chairman of the board of supervisors, had resigned in writing due to retirement. Fosun Pharma expressed its thanks to Ms. Ren Qian for her contributions during her term of office. On the same day, the company held a meeting of employee representatives and elected Ms. Wang Lina as the new employee supervisor, with a term of office from the date of election until the end of the ninth session of the board of supervisors. Ms. Wang Lina has rich experience in human resources management, and currently serves as the executive general manager of human resources department of Fosun Pharma and the vice president of Fosun Health Technology (Group) Co., Ltd., a subsidiary of Fosun Pharma. She joined the Fosun Pharma Group in 2007 and received a master's degree in management from Renmin University of China in 2013. As of June 19, 2024, Ms. Wang Lina holds 1,900 shares of A shares in Fosun Pharma.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.